memantine has been researched along with Exfoliation Syndrome in 1 studies
Exfoliation Syndrome: The deposition of flaky, translucent fibrillar material most conspicuous on the anterior lens capsule and pupillary margin but also in both surfaces of the iris, the zonules, trabecular meshwork, ciliary body, corneal endothelium, and orbital blood vessels. It sometimes forms a membrane on the anterior iris surface. Exfoliation refers to the shedding of pigment by the iris. (Newell, Ophthalmology, 7th ed, p380)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with memantine à 20 mg/d lasted for 6 months and was preceded by one week à 10 mg/d." | 1.31 | [Use of memantine in progressive glaucoma. Case report]. ( Erb, C; Schröder, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schröder, A | 1 |
| Erb, C | 1 |
1 other study available for memantine and Exfoliation Syndrome
| Article | Year |
|---|---|
[Use of memantine in progressive glaucoma. Case report].
Topics: Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Evoked Potentials, Visual; Exc | 2002 |